NeuroOne Medical Technologies Files 8-K

Ticker: NMTC · Form: 8-K · Filed: Mar 26, 2024 · CIK: 1500198

Neuroone Medical Technologies CORP 8-K Filing Summary
FieldDetail
CompanyNeuroone Medical Technologies CORP (NMTC)
Form Type8-K
Filed DateMar 26, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, SEC Filing, Routine Disclosure

Related Tickers: NEUR

TL;DR

NEUR filed a routine 8-K on 3/26/24, no major news.

AI Summary

NeuroOne Medical Technologies Corporation filed an 8-K on March 26, 2024, reporting other events and financial statements. The company, incorporated in Delaware, is based in Eden Prairie, MN, and operates in the surgical and medical instruments sector. This filing does not detail specific financial transactions or events beyond its routine reporting nature.

Why It Matters

This 8-K filing serves as a routine update for investors, indicating the company is adhering to its disclosure obligations with the SEC.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits,' indicating routine corporate disclosures rather than significant new developments.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing is for 'Other Events' and 'Financial Statements and Exhibits,' indicating routine corporate disclosures and adherence to SEC reporting requirements.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 26, 2024.

Where are NeuroOne Medical Technologies Corporation's principal executive offices located?

The principal executive offices are located at 7599 Anagram Dr., Eden Prairie, MN 55344.

What is the company's SIC code?

The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What was the former name of the company?

The former name of the company was Original Source Entertainment, Inc., with a date of name change on August 30, 2010.

Filing Stats: 444 words · 2 min read · ~1 pages · Grade level 11.8 · Accepted 2024-03-26 09:20:17

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On March 26, 2024, NeuroOne Medical Technologies Corporation (the "Company") issued a press release announcing that it expects to start shipping systems of its OneRF Ablation System this week in connection with a limited commercial launch. A copy of this press release is filed herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated March 26, 2024 104 Cover Page Interactive Data File (embedded with Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEUROONE MEDICAL TECHNOLOGIES CORPORATION Dated: March 26, 2024 By: /s/ David Rosa David Rosa Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing